arBtrage CAPITALIZING MARKETS checking… Sign in Sign up

Nuvalent, Inc.

NUVL Health Care Biotechnology: Pharmaceutical Preparations
$90.95
▼ -3.3% Today
as of Jun 7, 07:23 ET
Last 30 days -10.78% Apr 28 → Jun 05
$88.56 $94.42 $100.28 $106.15 $112.01 Apr 28 May 05 May 13 May 20 May 29 Jun 05
Open
$93.38
High
$94.08
Low
$90.42
Volume
$707,426
Avg Vol
$567,188
Mkt Cap
$8.6B
P/E (TTM)
Beta
52w High
$113.02
52w Low
$71.13
Div Yield
Shares Out

Overview

52-week range
$71
$113
47% of range
Avg surprise (last 2)
-3.2%
Avg reaction (last 2)
+2.8%
50% positive
Latest IV / EM
52%
EM ±7.1% · $90 · Jun 18

Earnings trends

EPS — actual vs estimate Actual Estimate
$-1.70$-1.40$-1.10$-0.81$-0.51 Actual $-0.51Actual $-0.59Actual $-0.69Actual $-0.88Actual $-1.28Actual $-1.18Est $-1.14Actual $-1.39Actual $-1.70Actual $-1.39Est $-1.35 JunSepMarJunSepMar/2025JunSepMar/2026
Revenue vs Net Income Revenue Net income
$-122M$-107M$-91M$-76M$-60M Jun 24Sep 24Mar 25Jun 25Sep 25Mar 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Thu May 7, 2026Mar/2026 $-1.39 $-1.35 -3.0% -17.8% -1.8% earnings
Tue Sep 30, 2025Sep 2025 $-1.70 financials
Mon Jun 30, 2025Jun 2025 $-1.39 financials
Thu May 8, 2025Mar/2025 $-1.18 $-1.14 -3.5% +7.3% earnings
Mon Sep 30, 2024Sep 2024 $-1.28 financials
Sun Jun 30, 2024Jun 2024 $-0.88 financials
Sun Mar 31, 2024Mar 2024 $-0.69 financials
Sat Sep 30, 2023Sep 2023 $-0.59 financials
Fri Jun 30, 2023Jun 2023 $-0.51 financials

Financials

Income statement (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Revenue
Cost of revenue
Gross profit
Operating income$-119M$-113M$-105M$-95M$-76M$-65M
Net income$-109M$-122M$-100M$-85M$-84M$-57M
EPS (diluted)$-1.39$-1.70$-1.39$-1.18$-1.28$-0.88

Balance sheet (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Cash & equivalents$160M$262M$116M$127M$121M$146M$369M$78M
Inventory
Total current assets$1.31B$1.39B$957M$1.02B$1.09B$1.13B$1.18B$666M
Total assets$1.33B$1.41B$980M$1.04B$1.11B$1.14B$1.19B$675M
Long-term debt
Total liabilities$157M$164M$135M$101M$95M$72M$68M$38M
Total equity$1.17B$1.25B$845M$940M$1.01B$1.07B$1.12B$637M

Implied volatility — last 90 days

46%49%51%54%56% Jun 07 — IV 52% · EM ±7.1%

Sector peers

🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.